Cairo: Ezdehar Management (Ezdehar), an Egypt-based private equity firm, announced the purchase of a minority stake at “Al-Tayseer Healthcare Group” through Ezdehar Egypt Mid-Cap Fund. The company’s investment comes within the framework of its strategy that aims to open new horizons in all fields, especially with regard to healthcare services. Ezdehar Egypt Mid-Cap Fund comprises contributions from several international institutions; foremost among them are the European Bank for Reconstruction and Development (EBRD), the European Investment Bank (EIB), UK’s CDC Group, and the Dutch Entrepreneurial Development Bank FMO.
Investing in Al-Tayseer Healthcare Group (THG) aims at supporting THG in consolidating its position as the largest healthcare provider in the underserved Delta region, investing in a number of hospitals in the pipeline, and expanding its chain of laboratories in the coming years.
THG has witnessed strong growth over the past five years, supported by the extension implemented at its flagship hospital, Al-Tayseer International Hospital in Zagazig, in addition to its acquisition of Hassab Labs; the leading chain of medical laboratories in Alexandria; and its investment into Mansoura Medical Center, the largest private hospital in Mansoura. The company has an ambitious expansion plan to increase the number of beds in Al-Tayseer International Hospital in Zagazig, the renovation and expansion of its hospital in Mansoura, and the inauguration of a new hospital in Meet Ghamr, increasing the group’s total number of beds to 495 beds. This enables the company to become one of the largest groups pertinent to the health services in Egypt.
In this context, Dr. Mohamed Gazar, co-founder and Chief Executive Officer (CEO) of THG, said: “We are proud that Ezdehar joined hands with us and contributed in THG’s journey of growth, which comes as an affirmation of the investors’ confidence in the company's performance in the past period, along with their belief in its ability to achieve success in the upcoming period.”
On his part, Emad Barsoum, Managing Director of Ezdehar said: “THG’s management team has extensive experience in the healthcare field, and an outstanding performance in providing high quality service at affordable prices. We look forward to providing the necessary support for them and increasing our investments in the company's hospitals and laboratories.” He added: "We aim to strengthen our efforts to develop the company's management, governance systems, and structure, in order to become one of the leaders in the sector of health services in Egypt."
KAMCO Investment Company played the role of THG’s financial advisor. Al Tamimi & Company Advocates & Legal Consultants was legal advisor for THG, while both offices; Matouk Bassiouni and Hinnawi Advocates & Legal Consultants, and the Dutch VCL provided legal advice to Ezdehar.
© Press Release 2020
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
